NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Telehealth. Priority Review Voucher Reauthorization. H.R.4408/S.1906: Promising Pathway Act (PPA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
| SUPRAJA SOWMIYANARAYAN | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. H.R.4758/S.2372: Accelerating Kids Access to Care Act. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. H.R.4408/S.1906: Promising Pathway Act (PPA). Lab-developed tests (LDTs) and genetic testing access. PRV Reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
| SUPRAJA SOWMIYANARAYAN | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. Advanced Research Projects Agency - Health (ARPA-H) Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.